Impact on Hospitalization Derived from the Use of Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastases Secondary to Breast Cancer in Germany

Value Health. 2014 Nov;17(7):A644-5. doi: 10.1016/j.jval.2014.08.2333. Epub 2014 Oct 26.

Authors

I Diel¹, R Ikenberg², J Cristino³, F Gatta³, Y Qian⁴, J Arellano⁴

Affiliations

¹ Praxisklinik am Rosengarten, Mannheim, Germany.
² Amgen GmbH, Munich, Germany.
³ Amgen (Europe) GmbH, Zug, Switzerland.
⁴ Amgen Inc., Thousand Oaks, CA, USA.

PMID: 27202315
DOI: 10.1016/j.jval.2014.08.2333

No abstract available